Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets.
Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions.
Air Lease Stock Up 43% as Investor Trims $6.9 Million Stake Despite $1 Billion Profit Year Air Lease Corporation provides global airlines with commercial jet leasing, sales, and fleet management services across a diverse portfolio.
Five9 Stock Down 60% This Past Year, but One Investor Just Lifted Stake With $3.5 Million Buy Five9 delivers cloud-based contact center software for enterprises, serving clients across finance, healthcare, and technology sectors.
Freshworks Stock Down 60% in One Year as Revenue Jumps 16% and One Investor Sells $7 Million in Shares Freshworks delivers cloud-based SaaS solutions for customer engagement, IT service management, and business process automation.
CareDx's CEO Conducts Multiple Sale of Shares Towards the End of January 2026 The CEO of this leading medical diagnostic company sold shares throughout multiple days in January. But the manner in which the shares were sold shouldn't concern investors.
CareDx President and CEO Sells 19,000 Shares for $412,000 This transplant diagnostics specialist saw a notable insider sale amid a year of modest share price decline and ongoing product innovation.
What's going on in today's after hours session Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential CareDx, Inc. faces uncertainty with proposed reimbursement changes, but has long-term potential in the $8 billion transplant solutions market.
CareDx Inc (NASDAQ:CDNA) Posts Mixed Q2 2025 Results Amid Revenue Adjustments and Testing Growth CareDx Inc (CDNA) reported mixed Q2 2025 results with revenue of $86.7M, missing estimates, but adjusted revenue rose 14% YoY. Testing volumes grew 13%, while shares fell 6.8% post-earnings.
